Accredited Compounding Pharmacy Verification Guide
Accredited Compounding Pharmacy. Verify compounding pharmacy credentials with NABP, USP, and LegitScript. Learn the steps that confirm safe, accredited
A compounded prescription looks simple on paper. The harder question is whether the pharmacy preparing it can do the work safely, document it properly, and prove it when asked. For patients managing GLP-1 therapy, tirzepatide, semaglutide, or even hair-retention protocols that depend on careful formulation and clean handling, that question isn't academic. It's the difference between a pharmacy that can show its controls and one that only says the right words.
A licensed pharmacy can legally operate, but licensure alone doesn't tell a prescriber or patient how strong the compounding controls are. Accreditation, USP chapter alignment, and third-party verification add measurable thresholds that can be checked before a prescription is filled. In practice, that means looking for documented sterile technique, ingredient traceability, engineering controls, and a current survey trail, not just a polished website or a seal on a footer. The safest workflow is to treat every claim as something that should be verified.
That matters because compounded preparations don't go through FDA pre-market review the way approved drugs do, so the burden shifts to the dispensing pharmacy. For sterile products, the room, the process, and the records all have to line up. When those pieces don't line up, the risk isn't theoretical. It shows up in contamination, mislabeled strengths, and prescriptions that leave the pharmacy without enough evidence behind them.
Table of Contents
- Why Compounding Pharmacy Verification Matters Before You Fill a Prescription
- What Defines an Accredited Compounding Pharmacy
- The Bodies That Accredit and Verify U.S. Compounding Pharmacies
- USP <795>, <797>, and <800> Standards Explained
- 503A Compounding Pharmacies Compared with 503B Outsourcing Facilities
- Step-by-Step Verification Workflow for Any Compounding Pharmacy
- How LegitScript Certification Fits Into the Verification Picture
- Detailed Entries on Major Compounding Accreditation Programs
- Sterile Compounding Thresholds Worth Verifying
- Documentation and Records to Request Before Dispensing
- Quick-Reference Verification Checklist
- Common Verification Questions After the Checklist
Why Compounding Pharmacy Verification Matters Before You Fill a Prescription
A patient usually reaches this decision point at the exact wrong time, with a medication already delayed, a refill running low, or a prescriber asking for a quick yes. That urgency is where poor verification habits start. The fastest way to lose control of the process is to assume that a pharmacy badge means the same thing as validated compounding practice.
The better frame is simple. State licensure says a pharmacy can operate. Accreditation says an outside body has checked specific quality systems against a defined standard. USP chapter adherence says the preparation process is tied to published compounding rules, and for sterile work those rules are not interchangeable with nonsterile work. A pharmacy can be legal and still not meet the right threshold for the dosage form in front of the patient.
Practical rule: if the pharmacy can't name the exact standard it compounds under, it hasn't given enough information yet.
For patients using GLP-1s or tirzepatide, the distinction matters even more. A vial label alone doesn't tell you whether the compound was prepared under sterile controls, whether the beyond-use date is tied to data, or whether the facility's inspection record is current. The rest of this guide is built as a verification script, not an acronym list.
The goal is to leave with a sequence that can be reused on every refill. Check the license, check the accreditor, check the USP chapter basis, then check the documents that prove the batch was prepared under those controls. That is the level of scrutiny a compounded prescription deserves.
What Defines an Accredited Compounding Pharmacy
An accredited compounding pharmacy is not just a pharmacy that compounds. It is a pharmacy that has gone through an outside review against a defined quality framework, usually with an on-site survey and supporting records. The difference sounds small until the first time a pharmacy can't produce a cleanroom certification, a training log, or a current survey summary.
License, accreditation, and the term accredited
A pharmacy license establishes legal authority to dispense. It does not by itself prove that the pharmacy has been benchmarked against compounding-specific controls. Accreditation adds a second layer, one that usually tests the details people miss in marketing copy, such as ingredient accountability, process documentation, environmental controls, and staff competency. For compounding, the threshold should always be tied to a named accreditor and a current directory entry.
That history matters. Compounding pharmacy accreditation became a formal quality signal in the U.S. when the Pharmacy Compounding Accreditation Board was established in 2007 by eight national pharmacy organizations, including the American Pharmacists Association, the National Association of Boards of Pharmacy, and the United States Pharmacopeia (PCAB and modern compounding accreditation background). The modern framework was updated again after USP chapter revisions became official on November 1, 2023 (USP chapter update context).
Sterile and nonsterile aren't interchangeable
Compounding also has to be judged by dosage form. A pharmacy may be strong in nonsterile capsules or creams and still be weak in sterile injectables. NABP's compounding accreditation framework explicitly ties review to USP <795>, USP <797>, and readiness for USP <800>, which keeps the evaluation anchored to the right chapter set rather than to a vague “quality” label (NABP compounding standards summary). For readers, that means the word accredited only matters if the certificate names the right accreditor and the right scope.
An accredited pharmacy should be able to tell a patient, without hesitation, which USP chapter governs the product on the script.
If the answer sounds fuzzy, the verification work isn't finished.
The Bodies That Accredit and Verify U.S. Compounding Pharmacies
Different bodies check different things, and confusion usually starts when one credential is used to imply another. A state board can license the pharmacy, a compounding accreditor can survey operations, and a certification body can verify a separate claim such as internet pharmacy compliance. Those are not the same job.
What each body is actually doing
NABP matters because it links state-board expectations with verification tools and compounding accreditation. Its Verified Pharmacy Program is part of the inspection path and serves as a prerequisite for its compounding accreditation process, which means the pharmacy has to clear operational checks before the accreditation application moves forward (NABP compounding accreditation overview). ACHC also offers compounding accreditation and is commonly associated with PCAB-accredited programs in practice. LegitScript is different, because it addresses online pharmacy and advertising compliance, not compounding quality. URAC is another possible accreditor, though less common in this niche.
What readers should not confuse
A state license is not accreditation. An online seal is not proof of sterile technique. A certificate for general internet pharmacy compliance is not proof that a sterile vial was prepared under the right hood, with the right environmental controls, by trained staff. The accreditor's name should appear on the certificate, and the pharmacy should be searchable in that body's public directory. If the seal can't be verified through the accreditor's own portal, treat it as decoration until proven otherwise.
| U.S. Compounding Pharmacy Accrediting and Verification Bodies | |||
|---|---|---|---|
| Body | Scope | Evaluates | Does Not Evaluate |
| NABP | Compounding accreditation and inspection support | USP chapter alignment, facility readiness, prerequisite inspection status | Patient-specific medical appropriateness |
| ACHC | Compounding accreditation track | Operational controls, survey-based quality review | State licensure authority |
| LegitScript | Online pharmacy compliance certification | Internet-facing transparency and advertising compliance | Sterile technique or compounding formulation quality |
| URAC | Alternate accreditation path | Organization-level quality review | The same thing as a state license |
USP <795>, <797>, and <800> Standards Explained
USP chapters define the thresholds. They tell a pharmacy what kind of compound is being made, which controls apply, and what documentation should exist before the product leaves the building. A pharmacy that can't identify the chapter basis for a fill is asking the reader to trust a label without checking the process.
What each chapter governs
USP <795> covers nonsterile compounding, including capsules, suspensions, and topical preparations. USP <797> covers sterile compounding, which USP defines as combining, admixing, diluting, pooling, reconstituting, repackaging, or otherwise altering a drug product or bulk drug substance to create a sterile preparation (USP <797> definition). USP <800> governs hazardous drugs regardless of sterility, so it matters whenever the ingredient profile creates a containment issue.
That chapter selection is driven by the dosage form and the hazard profile, not by marketing language. A nonsterile cream does not get the same controls as an injectable vial. A hazardous ingredient does not stop needing containment just because it's in a nonsterile process.
The 2023 sterile compounding update
USP <797> was revised in 2023 and became official on November 1, 2023, which tightened sterile preparation categories, beyond-use dating, training expectations, monitoring, and documentation (NABP summary of the revision). Professional summaries of that revision note changes to the handling of conventionally manufactured sterile products and longer allowable times for certain prepared doses under defined conditions. For a patient or prescriber, the practical point is that a pharmacy operating on old habits may be out of step with current sterile expectations.
Clinical takeaway: if a pharmacy says it is “USP compliant,” the next question is always, “Which chapter, which revision, and which product type?”
| USP Compounding Chapters Compared | ||
|---|---|---|
| Chapter | Governs | Key Thresholds |
| USP <795> | Nonsterile preparations | Formulation controls, stability support, documentation |
| USP <797> | Sterile preparations | Cleanroom controls, aseptic process, personnel qualification |
| USP <800> | Hazardous drugs | Containment strategy, deactivation, and handling controls |
503A Compounding Pharmacies Compared with 503B Outsourcing Facilities
Not every compounder operates under the same regulatory model. The practical difference is whether the pharmacy is compounding for identified patients under traditional state oversight or operating as an FDA-registered outsourcing facility with manufacturing-style controls. That distinction changes the level of documentation a patient should expect.
The 503A model
A 503A pharmacy compounds in response to identified patient prescriptions and operates under state board oversight and USP standards. It is not required to meet full CGMP. That makes the 503A model the more common fit for patient-specific prescriptions, where the pharmacy prepares a medication for a named person rather than for generalized stock.
The 503B model
A 503B outsourcing facility must register with FDA, comply with current Good Manufacturing Practice, and submit to FDA inspection on a risk-based schedule (FDA sterile compounding guidance and oversight framework). FDA guidance also describes environmental targets for aseptic processing, including ISO 7 for the area surrounding the ISO 5 aseptic zone, at least 10 to 15 Pascals positive pressure between adjacent rooms of differing classification, and ISO 8 minimum conditions when an isolator is used (FDA guidance). Those are useful design and audit benchmarks for sterile operations.
Which model shows up where
Office stock, hospital infusion, and high-volume sterile work are where 503B facilities are more likely to show up. Patient-specific refills are more often handled through 503A compounding pharmacies. A reader does not need to memorize the regulatory code. The useful question is whether the pharmacy is acting like a patient-specific compounding site or an FDA-registered outsourcing facility, because the records should match the model.
| 503A vs 503B Operational Comparison | ||
|---|---|---|
| Axis | 503A Pharmacy | 503B Outsourcing Facility |
| Oversight | State board and USP standards | FDA registration and CGMP |
| Prescription basis | Identified patient prescriptions | Can produce larger batches under 503B rules |
| Inspection cadence | State and accreditation dependent | FDA risk-based inspection |
| Likely use case | Patient-specific fills | Office stock and higher-volume sterile supply |
Step-by-Step Verification Workflow for Any Compounding Pharmacy
Verification works best in a fixed order. Start with the public records that are hardest to fake, then move toward the documents that prove the pharmacy produced the batch under the right controls. That sequence saves time and catches the most common problems early.
Run the checks in this order
State board license lookup. Confirm the license is active, in good standing, and lists compounding within scope. If the pharmacy can't clear the basic licensure check, nothing else matters yet.
NABP directory search. Search by the facility's NABP e-Profile information and confirm current PCAB or Compounding Pharmacy Accreditation status, plus the expiration date. A current directory record matters more than a logo on a website.
Survey summary review. Request the most recent third-party survey summary and note the USP chapter(s) the pharmacy compounds under. The summary should tell the reader whether the pharmacy is built for sterile, nonsterile, or hazardous work.
LegitScript check if online dispensing is involved. If the pharmacy ships across state lines or advertises online, confirm the certificate status through the public registry. This is especially relevant when the ordering pathway is digital.
Document request. Ask for the current cleanroom certification report, garbing and fingertip testing logs, and a Certificate of Analysis for the specific preparation being dispensed.
A clean website tells very little. A current certificate, dated engineering report, and batch-specific documents tell a lot.
Keep every artifact in one verification folder. That way, the next refill can be checked against the same trail without starting over.
How LegitScript Certification Fits Into the Verification Picture
LegitScript belongs in the online-dispensing part of the review, not in the sterile-technique part. It helps verify whether the pharmacy's internet-facing operations meet the compliance expectations attached to online pharmacy conduct, advertising, and related workflow standards. That makes it useful, but it's not a substitute for compounding accreditation.
What the certificate confirms
A valid LegitScript certificate supports the idea that the pharmacy's online presence is being monitored against pharmacy-legality and advertising rules. If a pharmacy is selling, advertising, or shipping through a website, that's a relevant safety gate. A patient can verify the certificate on the pharmacy site and cross-check the certificate ID in the public registry before assuming the order path is legitimate.
What it does not confirm
LegitScript does not tell a patient whether the cleanroom passed certification, whether the beyond-use date is supported by stability data, whether staff completed aseptic competency checks, or whether the pharmacy is aligned with USP <795>, USP <797>, or USP <800>. It doesn't replace the compounding survey. It doesn't tell the reader whether the lot was tested. It doesn't validate the pharmacist's process for a sterile injectable.
That separation matters for GLP-1 and tirzepatide workflows, where the ordering platform may look polished while the underlying compounding record is weak. A pharmacy can be compliant online and still need deeper compounding verification before a patient accepts the fill.
| LegitScript Certification: What It Covers and What It Excludes | |
|---|---|
| LegitScript Confirms | LegitScript Does Not Confirm |
| Online compliance and advertising review | Sterile technique |
| Public certificate and registry traceability | Beyond-use dating support |
| Pharmacy legitimacy in the internet channel | USP chapter readiness |
| Ongoing monitoring for rogue pharmacy signals | Master formulation record quality |
Detailed Entries on Major Compounding Accreditation Programs
The major accreditation programs address the same core challenge from slightly different perspectives. Readers should focus less on the acronym and more on what the survey evaluates, how often the status is renewed, and where the current record is maintained.
PCAB
The Pharmacy Compounding Accreditation Board was established in 2007 and later absorbed under NABP in 2014. Its purpose was to create a national quality signal for compounders by reviewing nonsterile, sterile, and hazardous compounding against USP-based expectations. In practical terms, it gives a pharmacy a structured way to show that policies, facilities, and staff behavior match the chapter set on the prescription.
NABP Compounding Pharmacy Accreditation
NABP's program is built around a state license, no recent disciplinary action, designated compounding space, and the prerequisite Verified Pharmacy Program inspection. NABP states that the inspection must be completed within 6 months of application, and its sterile compounding inspection framework includes operational requirements such as being open at least 8 hours per operational day, having compounded for at least 30 days before application, and holding engineering control certification reports dated within 6 months of the application payment date (NABP VPP inspection requirements). The program's public verification path is the NABP directory.
ACHC compounding accreditation
ACHC's compounding track is often used where survey emphasis leans heavily on documentation discipline and operational consistency. It remains a separate survey path from NABP's, so the pharmacy should be able to show which accreditor owns the certificate and where renewal lives in the public record.
| Comparison of PCAB, NABP, and ACHC Compounding Accreditation Programs | ||||
|---|---|---|---|---|
| Program | Founding / Owner | Tracks Offered | Survey Cadence | Public Verification Source |
| PCAB | Founded in 2007, later absorbed under NABP | Nonsterile, sterile, hazardous | Renewal cycle depends on current program terms | Accreditor directory |
| NABP Compounding Pharmacy Accreditation | NABP | Sterile and nonsterile tracks | On-site survey and renewal cycle tied to program terms | NABP directory |
| ACHC | ACHC | Compounding accreditation track | Renewal cycle tied to program terms | ACHC directory |
Sterile Compounding Thresholds Worth Verifying
Sterile work is where the room matters as much as the recipe. A pharmacy can have a valid license and still fail the environmental part of the job if the engineering controls, pressure relationships, or certification dates are out of range.
What the room should show
A sterile suite should be built around an ISO Class 5 primary engineering control, with surrounding ISO Class 7 and ISO Class 8 areas where applicable. The FDA's aseptic-processing guidance also identifies positive pressure of 10 to 15 Pascals between adjacent rooms of differing classification, and it uses ISO 7 and ISO 8 as the environmental benchmarks for the cleanroom design (FDA guidance). In practice, the reader should expect those values to appear in the cleanroom certification report or facility SOPs.
What the personnel file should show
Sterile competency isn't a one-time event. The documentation should show glove fingertip testing, media fill verification, and reassessment of aseptic technique. If the staff file doesn't show current training and a documented competency trail, the room controls are only half the story. NABP also requires documented training for staff involved in compounding as part of its inspection framework (NABP VPP inspection requirements).
Verification rule: no current room certification, no sterile fill review, no exception.
| Sterile Compounding Engineering and Personnel Thresholds to Verify | ||
|---|---|---|
| Threshold Category | Specific Value to Confirm | Source Standard |
| Primary engineering control | ISO Class 5 | USP/FDA sterile compounding guidance |
| Surrounding room classification | ISO Class 7 and ISO Class 8 areas as applicable | FDA guidance |
| Differential pressure | 10 to 15 Pascals positive pressure | FDA guidance |
| Staff competency | Training and aseptic verification documented | NABP inspection framework |
Documentation and Records to Request Before Dispensing
A pharmacy can say the right things and still leave gaps in the paper trail. The fastest way to test the setup is to ask for batch-specific records, not a brochure or a sales sheet.
What the batch file should contain
A Certificate of Analysis should match the lot number on the vial. That is the simplest traceability check and the one most likely to expose a substitution problem. For sterile preparations, the packet should also include sterility and endotoxin testing results, plus the reading dates, so the reader can tell whether the batch was tested and not just labeled as if it had been.
What supports the beyond-use date
The pharmacy should be able to show the stability source behind the beyond-use date. If the BUD is just written on the label with no supporting record, that is a documentation gap, not a quality system. Cold-chain shipping logs matter too, especially for temperature-sensitive formulations, because the product can be prepared correctly and still be compromised in transit.
What nonsterile files should show
For nonsterile compounds, ask for the formulation record, the active pharmaceutical ingredient lot and manufacturer, and the quality release signature. Those documents answer a basic question. Can the batch be traced, and did someone with authority release it?
Quick-Reference Verification Checklist
A clean verification process stays short enough to reuse. The sequence below goes from the fastest public check to the deeper batch-level review, so a refill doesn't turn into a scavenger hunt.
State board license. Search the state board database and confirm the pharmacy license is active and in good standing. A pass means the license is current and compounding is within scope.
NABP directory entry. Search the NABP compounding accreditation directory by facility name and address, and confirm the accreditation is current. A fail means the accreditor does not list the pharmacy or the status is expired.
Third-party scope summary. Request the current survey summary and identify the USP chapter basis. A pass means the summary matches the intended dosage form.
Cleanroom certification report. Review the most recent report and confirm the recertification date is current. A stale report is a stop sign.
LegitScript registry. Verify the certificate ID in the registry if the pharmacy advertises or dispenses online. A pass means the certificate is active and traceable.
FDA outsourcing facility registry. For 503B work, confirm the facility appears in the FDA listing. A fail means the facility shouldn't be treated as a registered outsourcing operation.
Run the checklist again annually, or sooner after any ownership change or status shift. One current file is useful. A current file that gets refreshed is safer.
Common Verification Questions After the Checklist
A cross-border fill usually raises the first practical question. The answer is simple, each state still controls licensure where it applies, so reciprocity does not erase the need to verify the dispensing pharmacy's authority in the patient's state. If the pharmacy ships to multiple states, the state board record and the online compliance record both need to be current.
The three red flags that should stop a shipment are easy to name. Missing COAs, expired cleanroom or engineering certification, and an unlisted compounding location. Any one of those means the pharmacy has not proved the fill the way it should.
If accreditation changes during an ongoing treatment relationship, ask for the corrective-action record and the date the issue was resolved. If the answer is vague or the documentation doesn't follow, escalation to the state board is the same-day move. A pharmacy that says it follows USP but has no third-party accreditation still needs to show the actual chapter basis, the survey trail, and the batch records. The burden doesn't go away just because the seal is missing.
That same standard applies to metabolic therapies and hair-retention formulations. The prescriber still needs a pharmacy that can show the right chapter, the right room, and the right record before the patient accepts the dose.
Vials + Vitals works with protocol-driven therapies that depend on disciplined pharmacy selection, especially for GLP-1 and hair-health treatments where the fill quality matters as much as the prescription itself. If a patient or clinician needs a clearer way to evaluate a dispensing pharmacy before starting care, visit Vials + Vitals and review how accredited U.S. pharmacy fulfillment fits into a supervised treatment pathway.
Ready to see if this protocol fits your biology?
A licensed provider reviews every request before anything is prescribed.
Calibrate your metabolic protocol →